Rapid and Point-of-Care Diagnostic Tests for SARS-COV-2 (COVID-19): A Rapid Summary of Tests Available in Canada
Ontario Ministry of Health and Long-Term Care
- Canadian Institutes of Health Research (CIHR) through the Strategy for Patient-Oriented Research (SPOR) Evidence Alliance
To (1) determine what point-of-care diagnostic tests for SARS-COV-2 (COVID-19) are available in Canada; (2) determine how accurate the point-of-care diagnostic tests authorized in Canada are at identifying individuals with COVID-19; (3) identify what recommendations and guidelines exist for the use of point-of-care diagnostic tests to identify individuals with COVID-19; and (4) identify what the key benefits and limitations are of the point-of-care diagnostic tests for COVID-19 authorized in Canada.
Shannon Kelly currently manages and works as a senior research methodologist in the Heath Technology Assessment Unit of the Cardiovascular Research Methods Centre (CRMC) at the University of Ottawa Heart Institute where she focusses her work on advancing the science of evidence synthesis, research design and methodology. Her team conducts evidence syntheses to inform health care practice and policy. In this capacity, she has worked with a number of organizations nationally and internationally, including the Canadian Agency for Drugs and Technologies in Health (CADTH), the Public Health Agency of Canada, the World Health Organization and the Cochrane Collaboration.
Shannon is currently a PhD candidate in the Faculty of Medicine, School of Epidemiology and Public Health at the University of Ottawa and a trainee with the Cardiovascular Network of Canada (CANet) National Centre of Excellence. In her capacity with CANet, she sits on the Board of Directors. Shannon has been actively involved with post-market Drug Safety and Effectiveness Network (DSEN) since 2011 and has led numerous research projects for the Ontario Drug Policy Research Network, the Canadian Collaboration for Network Meta-analysis (CCNMA), the Methods and Application Group for Indirect Comparisons (DSEN- MAGIC) and the POst-market Drug Evaluation Team (PODET). In addition, Shannon leading a working group to develop nutrition-specific risk of bias tools (NUQUEST).